| Literature DB >> 17049383 |
Yuichi Sato, Naoya Matsumoto, Noriko Kinukawa, Shinro Matsuo, Sei Komatsu, Taeko Kunimasa, Shunichi Yoda, Shigemasa Tani, Tadateru Takayama, Yuji Kasamaki, Satoshi Kunimoto, Satoru Furuhashi, Motoichiro Takahashi, Satoshi Saito.
Abstract
Primary cardiac malignant lymphomas are extremely rare and the majority of lymphomas are aggressive B-cell lymphomas. We describe a patient with primary cardiac B-cell lymphoma presenting with superior vena caval syndrome and dyspnea. The tumors manifested as hypoechoic immobile masses on echocardiography, poorly enhancing masses on contrast-enhanced multislice computed tomography and iso-intense masses on T1-weighted and hyper-intense masses on T2-weighted magnetic resonance images. Pathologic examination revealed that the mass was consistent with B-cell malignant lymphoma. Systemic chemotherapy together with monoclonal CD 20 antibody treatment was initiated. There was marked regression of the tumor 4 days after the treatment and complete disappearance of the tumor after 8 days after the treatment without episodes of systemic or pulmonary embolism.Entities:
Mesh:
Substances:
Year: 2006 PMID: 17049383 DOI: 10.1016/j.ijcard.2006.07.090
Source DB: PubMed Journal: Int J Cardiol ISSN: 0167-5273 Impact factor: 4.164